FindTrial
Sign In

PARA-AORTIC LYMPH NODE INVOLVEMENT IN EPITHELIAL OVARIAN CANCER A PROSPECTIVE STUDY

PARA AORTIC LYMPH NODAL MAPPING IN EPITHELIAL OVARIAN CANCER A PROSPECTIVE COHORT STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/02/040347
Enrollment
20
Registered
2022-02-16
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C569- Malignant neoplasm of unspecifiedovary

Interventions

None listed

Sponsors

ALL INDIA INSTITUTE OF MEDICAL SCIENCES
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with epithelial ovarian cancers who undergo systematic retroperitoneal lymph node dissection as part of their cytoreductive surgery (Primary/Interval/Secondary) at AIIMS Rishikesh & AIIMS Jodhpur 2. Patients aged 18 to 80 years 3. Willing to participate in the study (written informed consent)

Exclusion criteria

Exclusion criteria: 1.Previous retroperitoneal lymph node dissection/surgery for any reason 2.Non curative surgery 3.Incomplete/Inadequate retroperitoneal lymph node dissection (for any reason) as deemed by the operating surgeon 4.Concurrent second malignancy

Design outcomes

Secondary

MeasureTime frame
Radiological and Pathological correlation of para-aortic nodal metastases in ovarian cancer patientsTimepoint: at baseline;To determine 30 day surgical morbidityTimepoint: 30 days;To determine the quality of life outcomes using EORTC QLQ-C30 questionnaireTimepoint: 30 days—

Primary

MeasureTime frame
para-aortic nodal involvementTimepoint: at baseline—

Countries

India

Contacts

Public ContactAVIJIT MONDAL

ALL INDIA INSTITUTE OF MEDICAL SCIENCES

drksrajkumar@gmail.com9940155250

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026